Literature DB >> 27332921

Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea.

Helen Fifer1, Usha Natarajan2, Lucy Jones2, Sarah Alexander3, Gwenda Hughes3, Daniel Golparian4, Magnus Unemo4.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27332921     DOI： 10.1056/NEJMc1512757

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  113 in total

1.  Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for Azithromycin.

Authors:  Ellen N Kersh; Vanessa Allen; Eric Ransom; Matthew Schmerer; Sancta Cyr; Kim Workowski; Hillard Weinstock; Jean Patel; Mary Jane Ferraro
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

2.  Neisseria cinerea with High Ceftriaxone MIC Is a Source of Ceftriaxone and Cefixime Resistance-Mediating penA Sequences in Neisseria gonorrhoeae.

Authors:  Gene Igawa; Yuka Yamagishi; Ken-Ichi Lee; Misato Dorin; Ken Shimuta; Hiroyuki Suematsu; Shu-Ichi Nakayama; Hiroshige Mikamo; Magnus Unemo; Makoto Ohnishi
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

3.  Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.

Authors:  L Ryan; D Golparian; N Fennelly; L Rose; P Walsh; B Lawlor; M Mac Aogáin; M Unemo; B Crowley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-07       Impact factor: 3.267

4.  Changing antimicrobial susceptibility and molecular characterisation of Neisseria gonorrhoeae isolates in Guangdong, China: in a background of rapidly rising epidemic.

Authors:  Xiaolin Qin; Yunhu Zhao; Wei Chen; Xingzhong Wu; Sanmei Tang; Guozhou Li; Yu Yuqi; Wenling Cao; Xiaofeng Liu; Jinmei Huang; Jieyi Yang; Wentao Chen; Weiming Tang; Heping Zheng
Journal:  Int J Antimicrob Agents       Date:  2019-08-16       Impact factor: 5.283

5.  Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.

Authors:  Carolien M Wind; Maarten F Schim van der Loeff; Alje P van Dam; Henry Jc de Vries; Jannie J van der Helm
Journal:  Euro Surveill       Date:  2017-01-05

6.  A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection.

Authors:  Aleksandra E Sikora; Carolina Gomez; Adriana Le Van; Benjamin I Baarda; Stephen Darnell; Fabian G Martinez; Ryszard A Zielke; Josephine A Bonventre; Ann E Jerse
Journal:  Vaccine       Date:  2020-11-05       Impact factor: 3.641

7.  Persistence Dynamics of Antimicrobial-Resistant Neisseria in the Pharynx of Rhesus Macaques.

Authors:  Eliza Thapa; Hanna M Knauss; Benjamin A Colvin; Benjamin A Fischer; Nathan J Weyand
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

8.  Real-Time PCR Targeting the penA Mosaic XXXIV Type for Prediction of Extended-Spectrum-Cephalosporin Susceptibility in Clinical Neisseria gonorrhoeae Isolates.

Authors:  L K Wong; P Hemarajata; O O Soge; R M Humphries; J D Klausner
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

9.  Selective Inhibition of Neisseria gonorrhoeae by a Dithiazoline in Mixed Infections with Lactobacillus gasseri.

Authors:  Jonathan D Lenz; Kristina A Shirk; Adrienne Jolicoeur; Joseph P Dillard
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

10.  Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants.

Authors:  Fadi E El-Rami; Ryszard A Zielke; Teodora Wi; Aleksandra E Sikora; Magnus Unemo
Journal:  Mol Cell Proteomics       Date:  2018-10-23       Impact factor: 5.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.